Successfully handling rejection reviews, based on a prior similar mark, in the past has proven difficult. Rather than simply giving up registration of an important trademark, recent China Trademark Review and Adjudication Board (TRAB) decisions indicate that an effective alternative for applicants is trying to reach a co-existence agreement with the owner of the cited
Intellectual Property
Viagra Judgment: Impact on future patent filings?
By King and Wood on
Posted in Intellectual Property
Written By Yang Hongjun, Partner
The recent decision by the Beijing Higher People’s Court revoking the Patent Reexamination Board (PRB) invalidation Decision of Pfizer’s Viagra Patent in China has put an indefinite end to a drawn out battle between domestic drug companies and Pfizer. This case, while not firmly establishing any foundation for patent examinations, has revealed many of the risks associated for all parties in proceeding into a legal dispute regarding patents in China. Continue Reading Viagra Judgment: Impact on future patent filings?